FDA Investigator Florecia S Philogene
Florecia S Philogene has conducted inspections on 66 sites in 1 countries as of 17 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
66
Last Inspection Date:
17 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Florecia S Philogene:
Adam C Hipko,
Akbar J Zaidi,
Alcee M Tavarez,
Alokita N Karmakar,
Anh M Lac,
Anthony L Smith,
Arie R Dyk,
Axel M Ambert,
Betsy C Galliher,
Blondell W Johnson,
Brandi E Williams,
Carol A Declouette Wilburn,
Cathleen A Castellaw,
Chad J Whitwell,
Charles B Steinmiller,
Charles D Brown,
Cheneysc,
Christopher J Hurst,
Christopher J Smith,
Constance M Dobbins,
Daniel S Fam,
Danielle Lyke,
Danny D Horner,
Darla J Christopher,
Deniza Karacic,
Ed Gonzalez Vazquez,
Edmiston,
Edward D Edmiston,
Emilio O Escobar,
Erick G Marchan,
Everard A Irish,
Fernando C Martinez,
Floyd D Herd,
Frans E Mercado,
Frederic W French, III,
Gatica,
Gery M Duparc,
Habacuc V Barrera,
Hung V Le,
Iris C Macinnes,
J Elkins,
Jacob S Foster,
Jamie M Bumpas,
Jennifer D Young,
Jennifer O Dowdy,
Jodi M Gatica,
Johann M Fitch,
Johnson,
Jonaida Estevez Martinez,
Jonathan A Womack,
Jonathan M Mcbride,
Joy L Ramsey,
Juan D Lopez,
Julio C Muraira,
Justin A Boyd,
Kamara Tx,
Karen C Daugherty,
Kari M Johansen,
Kathleen Chmura Shaffer,
Kayla R Deatherage,
Kenitra D Hewitt,
Kristi B Panzer,
Kristin N Longfellow,
L Grant,
Lauren E Skokan,
Liliana Cantu,
Lisa M Puttonen,
Lisa R Jennings,
Lloyd D Payne,
Maira P Brading,
Mark A Guerra,
Martha S Baldwin,
Micmarie Ramos Rodriguez,
Monique Rac Lester,
Ninfa N Innocent,
Patty P Kaewussdangkul,
Paulene M Wohlgemuth,
Payne,
Rebecca Co Bryan,
Rendall E Barfoot,
Rene R Ramirez,
Rian L Pope,
Richard T Riggie,
Robert M Tillman,
Robert T Lorenz,
Ronan F King,
Roy Baby,
Samuel A Hamblin,
Sandy J Ziegler,
Scott T Ballard,
Selina M Mata,
Sha'tina R Alridge,
Shannon A Lowe,
Staci G Mcallister,
Storm Vancuso,
Tamera H Hunt,
Tara A Gray,
Terrance L Thomas,
Thomas Martinez,
Torrance J Slayton,
Travis S Brown,
Tricia S Martinez,
Trina K Vick,
William H Shackelford
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more